Chlorpromazine Hydrochloride
Average across 43 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Upsher-Smith Laboratories, LLC | unknown | 12 | SUPPLYING |
| Zydus Pharmaceuticals USA Inc. | generic | 10 | SUPPLYING |
| Zydus Lifesciences Limited | generic | 10 | SUPPLYING |
| Glenmark Pharmaceuticals Inc., USA | generic | 10 | SUPPLYING |
| REMEDYREPACK INC. | repackager | 7 | SUPPLYING |
| American Health Packaging | repackager | 6 | SUPPLYING |
| Amneal Pharmaceuticals LLC | generic | 5 | SUPPLYING |
| NORTHSTAR RX LLC | relabeler | 5 | SUPPLYING |
| AvPAK | repackager | 5 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit — Recalling firm: Zydus Pharmaceuticals (USA) Inc — Nationwide in the USA
CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit — Recalling firm: Zydus Pharmaceuticals (USA) Inc — Nationwide in the USA
CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit — Recalling firm: Zydus Pharmaceuticals (USA) Inc — Nationwide in the USA
CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit — Recalling firm: Zydus Pharmaceuticals (USA) Inc — Nationwide in the USA
CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit — Recalling firm: Zydus Pharmaceuticals (USA) Inc — Nationwide in the USA
CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit — Recalling firm: Zydus Pharmaceuticals (USA) Inc — Nationwide in the USA
CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit — Recalling firm: Zydus Pharmaceuticals (USA) Inc — Nationwide in the USA
CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit — Recalling firm: Zydus Pharmaceuticals (USA) Inc — Nationwide in the USA
CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit — Recalling firm: Zydus Pharmaceuticals (USA) Inc — Nationwide in the USA
CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit — Recalling firm: Zydus Pharmaceuticals (USA) Inc — Nationwide in the USA
Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging at the manufacturing site, was detected with presence of a micro-organism. No micro-organism was detected on any tablets. — Recalling firm: Amerisource Health Services LLC — Nationwide in the USA
Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging at the manufacturing site, was detected with presence of a micro-organism. No micro-organism was detected on any tablets. — Recalling firm: Amerisource Health Services LLC — Nationwide in the USA
Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging at the manufacturing site, was detected with presence of a micro-organism. No micro-organism was detected on any tablets. — Recalling firm: Amerisource Health Services LLC — Nationwide in the USA
Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging at the manufacturing site, was detected with presence of a micro-organism. No micro-organism was detected on any tablets. — Recalling firm: Amerisource Health Services LLC — Nationwide in the USA
Presence of a foreign substance. — Recalling firm: AvKARE — USA Nationwide
Presence of a foreign substance. — Recalling firm: AvKARE — USA Nationwide
Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a micro-organism. No micro-organism was detected on any tablets. — Recalling firm: Amneal Pharmaceuticals, LLC — Distributed Nationwide in the USA
Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a micro-organism. No micro-organism was detected on any tablets. — Recalling firm: Amneal Pharmaceuticals, LLC — Distributed Nationwide in the USA
Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a micro-organism. No micro-organism was detected on any tablets. — Recalling firm: Amneal Pharmaceuticals, LLC — Distributed Nationwide in the USA
Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a micro-organism. No micro-organism was detected on any tablets. — Recalling firm: Amneal Pharmaceuticals, LLC — Distributed Nationwide in the USA
CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit — Recalling firm: Zydus Pharmaceuticals (USA) Inc — Nationwide within U.S - MS, AL, TN, VT, OH, ND, MN, WI, SC, AR, FL, IN, LA, NJ, AZ, TX, KY and PA
CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit. — Recalling firm: Glenmark Pharmaceuticals Inc., USA — Nationwide in the USA and PR
CGMP Deviations: N-Nitroso-Desmethyl Chlorpromazine impurity (NNDCI) were found to be failing per current FDA recommended limit. — Recalling firm: Glenmark Pharmaceuticals Inc., USA — USA Nationwide
